Probiotics for the prevention of gestational diabetes in overweight and obese women.

Not Applicable

Recruiting

• Conditions: Gestational diabetes; overweight/obesity; Metabolic and Endocrine - Diabetes; Diet and Nutrition - Obesity; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy

• Registration Number: ACTRN12611001208998
• Lead Sponsor: Royal Brisbane and Women's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-11-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 540

Inclusion Criteria

BMI greater than 25
Can read and understand English
Less than 16 weeks pregnant

Exclusion Criteria

Gestation >16 weeks
Pre-existing type 1 or type 2 diabetes
Pre-existing impaired fasting glucose or impaired glucose tolerance
GDM on early screening
Medications likely to influence glucose metabolism (eg metformin, glucocorticoids, immunosuppressants)
Medical conditions associated with altered glucose metabolism -eg Cushings, cirrhosis of the liver
Known fetal abnormality on the 12-13 week ultrasound scan
Known ingestion of probiotics via capsule

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
gestational diabetes on oral glucose tolerance test at 28 weeks gestation.[28 weeks gestation]